Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U01AI066007 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to learn whether or not all children with ear infections (acute otitis media or AOM) should be treated with antibiotics. The study will compare two treatment strategies, "watchful waiting" or treatment with antibiotics, to determine which is more appropriate for children with AOM. About 268 children in Pittsburgh, between the ages of 6-23 months, with AOM will be enrolled in the study. They will be treated either with Augmentin (an antibiotic) or placebo for 10 days and closely followed for about 1 month. Parents will be asked to write information about their child in a Patient Diary. A general physical exam, including an ear exam, will be performed 4 times during the study. A mucus sample will be collected from the back of each child's nose. Parents will be asked questions during phone calls and at every visit. If a child has not improved or has worsened, the investigators will prescribe a different antibiotic that is known to kill resistant germs.
The purpose of this randomized, double-masked, placebo-controlled, single-center clinical trial is to determine the efficacy of antimicrobials in young children with acute otitis media (AOM). The primary objectives are to compare time to resolution of symptoms (initial and sustained) in children receiving amoxicillin-clavulanate (90/6.4mg/kg/day in 2 divided doses for 10 days) to children receiving placebo (in 2 divided doses for 10 days), and to compare the weighted average AOM-Severity of Symptoms (AOM-SOS) scores in the two groups during days 1-7. The secondary objectives are to: evaluate the clinical efficacy of amoxicillin-clavulanate vs. placebo at the on-therapy visit (Day 4-5, and at least 72 hours after initial dose of study medication); evaluate the clinical efficacy of amoxicillin-clavulanate vs. placebo at the end-of-therapy visit (Day 10-12); compare AOM-SOS and AOM-Faces scales between treatment groups during each of the first 7 days of therapy and at all study visits; compare the proportion of children in each treatment group who develop worsening symptoms before having received 72 hours of study medication; compare the two treatment groups regarding the quantity of analgesic medication administered by children's parents; compare the incidence of adverse events accompanying the two treatment regimens; compare the effects of amoxicillin-clavulanate vs. placebo on the overall proportion of children with nasopharyngeal (NP) colonization with AOM pathogens (S. pneumoniae, H. influenzae, M. catarrhalis, S. pyogenes), and on the proportion of children with NP colonization with penicillin non-susceptible S. pneumoniae; compare the 2 treatment groups regarding tympanometric outcomes at the on-therapy (Day 4-5), end-of-therapy (Day 10-12) and follow-up (Day 21-25) visits, using an algorithm that permits estimation of the probability of middle ear effusion given any particular tympanographic configuration; compare direct and indirect medical costs between the two treatment groups; and compare parental satisfaction with therapy between the two treatment groups. Participants will include 268 children, aged 6 to 23 months, diagnosed with acute otitis media in Western Pennsylvania. These participants will be recruited into the study at Children's Hospital of Pittsburgh (CHP), Pittsburgh, PA, and Armstrong Pediatrics (Children's Community Pediatrics: an affiliate of CHP) in Kittanning, PA. Subjects will be randomized to receive either amoxicillin-clavulanate or placebo twice daily for 10 days. Parents of the subject will be asked to track symptom status, medication use (study medication and acetaminophen), fever and diarrhea in a study memory aid. Study procedures will include a medical history, vital signs, weight, clinical information regarding signs and symptoms of infection, nasopharyngeal specimens, and a physical exam including tympanometry. Each child will be examined three additional times: 4-5 days after starting the medicine, study day 10-12 and 21-25 days after enrolling in the study. During these visits, study staff will review the child's symptoms and examine the child's ears. The study staff will also obtain a nasopharyngeal culture in order to look for resistant bacteria and to make appropriate changes in antibiotic treatment. Daily telephone assessments will be made by study staff on days 2, 3, and 4 of therapy to make sure the child is getting better. The study staff will see a child anytime a parent feels their child has not improved or has worsened.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Amoxicillin-clavulanate | Experimental | Reconstituted amoxicillin-clavulanate at 90/6.4 mg/kg/day in 2 divided doses for 10 days. |
|
| Placebo | Placebo Comparator | Reconstituted placebo in 2 divided doses for 10 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| amoxicillin-clavulanate | Drug | Augmentin ES-600â„¢: Amoxicillin-clavulanate potassium (600/42.9 mg per 5 mL), administered at a dose of 90/6.4 mg/kg/day in 2 divided doses for 10 days with strawberry cream flavor. |
| Measure | Description | Time Frame |
|---|---|---|
| The Time to Resolution of Symptoms, Defined as Acute Otitis Media-Severity of Symptoms (AOM-SOS) Score of 0 or 1, According to Treatment Assignment | Time to resolution of symptoms is defined as the time from randomization until a child's AOM-SOS score reaches 0 or 1. The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) and recorded the ratings in a diary following enrollment on Day 1, twice daily Days 2 and 3, then once daily Days 4-7. Each set of ratings was summed to obtain an AOM-SOS score. The maximum possible score was 14 and the minimum was 0. A score >=3 was required to be enrolled in the study. | The first 7 days on therapy |
| The Time to Resolution of Symptoms, Defined as Acute Otitis Media-Severity of Symptoms (AOM-SOS) Score of 0 or 1 on Two Consecutive Occasions, According to Treatment Assignment | Time to resolution of symptoms is defined as the time from randomization until a child's AOM-SOS score reaches <= 1 on two consecutive occasions. The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) & recorded the ratings in a diary following enrollment on Day 1, twice daily Days 2 & 3, & once daily Days 4-7. Each set of ratings was summed to obtain an AOM-SOS score. The maximum possible was 14 and the minimum 0. A score >=3 was required to be enrolled in the study. | The first 7 days on therapy |
| The Weighted Average Acute Otitis Media - Severity of Symptom (AOM-SOS) Score, According to Treatment Assignment | The AOM-SOS score is derived from parent scoring each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) associated with AOM as 0, 1 or 2 (none, a little, a lot). The AOM-SOS was administered twice daily the first 3 days of follow-up, then daily for 4 additional days. Symptom burden for each child is determined by calculating the weighted average of symptom scores post-enrollment over the first 7 days of therapy. Scores are weighted by 1/k, where k is the number of post-enrollment assessments taken on that day. |
| Measure | Description | Time Frame |
|---|---|---|
| The Distribution of Clinical Failures by the On-therapy Visit According to Treatment Assignment | Clinical failure by the on-therapy visit is defined as either failure to achieve substantial improvement in symptoms, or worsening of otoscopic signs, or both. | On-therapy visit. The mean day for this visit was 5.0. |
Not provided
Inclusion Criteria:
aged 6 to 23 months
have received at least two doses of pneumococcal conjugate vaccine (Prevnar) and Haemophilus influenzae type B vaccine
have evidence of acute otitis media (AOM) defined as:
decreased or absent tympanic membrane mobility by pneumatic otoscopy,
yellow or white discoloration of the tympanic membrane,
opacification of the tympanic membrane, plus
1+ bulging of the tympanic membrane with either marked erythema or otalgia, or
2+ or 3+ bulging of the tympanic membrane
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alejandro Hoberman, MD | University of Pittsburgh | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37171965 | Derived | Shaikh N, Hoberman A, Paradise JL, Rockette HE, Kurs-Lasky M, Martin JM. Association Between Nasopharyngeal Colonization and Clinical Outcome in Children With Acute Otitis Media. Pediatr Infect Dis J. 2023 Aug 1;42(8):e274-e277. doi: 10.1097/INF.0000000000003956. Epub 2023 Apr 26. | |
| 21226576 | Derived | Hoberman A, Paradise JL, Rockette HE, Shaikh N, Wald ER, Kearney DH, Colborn DK, Kurs-Lasky M, Bhatnagar S, Haralam MA, Zoffel LM, Jenkins C, Pope MA, Balentine TL, Barbadora KA. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011 Jan 13;364(2):105-15. doi: 10.1056/NEJMoa0912254. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There were 2 children who signed consents but were not randomized. One parent withdrew consent and one child, referred from an outside practice, was found to not be eligible.
Children were recruited over 3 respiratory seasons, beginning on 11/31/2006 with the last enrollment on 3/31/2009. There were 2 enrollment sites, as well as referrals from private pediatricians. One site was a large private practice; the other was a large hospital based practice. This was for generalizability.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Amoxicillin-Clavulanate | Reconstituted amoxicillin-clavulanate at 90/6.4 mg/kg/day in 2 divided doses for 10 days. |
| FG001 | Placebo | Reconstituted placebo in 2 divided doses for 10 days. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Amoxicillin-Clavulanate | Reconstituted amoxicillin-clavulanate at 90/6.4 mg/kg/day in 2 divided doses for 10 days. |
| BG001 | Placebo | Reconstituted placebo in 2 divided doses for 10 days. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Customized | Number |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary | The Distribution of Clinical Failures by the On-therapy Visit According to Treatment Assignment | Clinical failure by the on-therapy visit is defined as either failure to achieve substantial improvement in symptoms, or worsening of otoscopic signs, or both. | The analysis was ITT. The number of participants equals the number of children followed at least 72 hours after the initial dose of study medication plus the number of children meeting the criteria for clinical failure less than 72 hours after the initial dose of study medication. | Posted | Number | participants | On-therapy visit. The mean day for this visit was 5.0. |
|
We monitored children and queried parents regarding adverse events at each study visit, i.e. Day 4-5, Day 10-12, and Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8.
A condition present at enrollment was recorded in the Review of Systems, not as an Adverse Event. However, if this condition worsened or developed after the enrollment visit, we reported this as an Adverse Event.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Amoxicillin-Clavulanate | Reconstituted amoxicillin-clavulanate at 90/6.4 mg/kg/day in 2 divided doses for 10 days. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Mastoiditis | Ear and labyrinth disorders | NIH Toxicity Tables | Systematic Assessment | One child was diagnosed with an early mastoiditis at the on-therapy visit. Middle ear culture yielded serotype 19A S. pneumoniae. The child was hospitalized and recovered uneventfully. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Asthma or wheezing | Respiratory, thoracic and mediastinal disorders | NIH Toxicity Tables | Systematic Assessment |
Long-term implications of abnormal otoscopic findings (bulging) without symptoms, and persistent middle-ear effusion without findings of acute inflammation as forerunners of subsequent acute otitis media episodes remains uncertain.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Efficacy of Antimicrobials in Young children with Acute Otitis Media | Children's Hospital of Pittsburgh of UPMC | 412-692-5249 | Hoberman@chp.edu |
Not provided
| ID | Term |
|---|---|
| D010033 | Otitis Media |
| ID | Term |
|---|---|
| D010031 | Otitis |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019980 | Amoxicillin-Potassium Clavulanate Combination |
| ID | Term |
|---|---|
| D019818 | Clavulanic Acid |
| D002969 | Clavulanic Acids |
| D047090 | beta-Lactams |
| D007769 | Lactams |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Placebo | Drug | Same base formulation of the licensed product Augmentin ES-600â„¢, with the same strawberry cream flavor. |
|
| During the first 7 days of therapy |
| The Distribution of Clinical Failures by the End-of-therapy Visit According to Treatment Assignment |
Clinical failure by the end of therapy visit is defined as failure to achieve complete or virtually complete resolution of symptoms and of otoscopic signs, but without regard to the persistence of middle ear effusion. |
| End-of-therapy visit. The mean day for this visit was 11.6. |
| The Mean Acute Otitis Media - Severity of Symptom (AOM-SOS) Score, Post-enrollment, Over the First 7 Days of Therapy According to Treatment Assignment | The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) and recorded the ratings in a diary following enrollment on Day 1, twice daily Days 2 and 3, then once daily Days 4-7. Each set of ratings was summed to obtain an AOM-SOS score as a measure of symptom burden. The maximum possible score was 14 and the minimum was 0. | During the first 7 days of therapy |
| The Distribution of Children Developing Worsening Symptoms Prior to Receiving 72 Hours of Study Medication According to Treatment Assignment | The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) and recorded the ratings in a diary following enrollment on Day 1 and twice daily Days 2 and 3. Each set of ratings was summed to obtain an Acute Otitis Media-Severity of Symptoms (AOM-SOS) score. We compared a child's AOM-SOS scores in the first 72 hours to his/her score at enrollment to determine if a child's symptoms got worse (score increased) or remained unchanged or improved (score remained same or decreased). | Before receiving 72 hours of study medication |
| The Mean Number of Times Analgesic Medication Was Administered to the Child According to Treatment Assignment | The parents were asked to complete a memory aid for the first 10 days of the study. One item asked them to record medications administered to the child in addition to the study medication. The data presented shows the mean number of times analgesic, i.e. ibuprofen or acetaminophen, was administered. | The first 10 days of follow-up |
| The Distribution of Children With Observed or Parent Reported Adverse Events or Complications According to Treatment Assignment | Analysis was limited to those adverse events identified as being associated with either the study medication or the antimicrobials administered to children who were treatment failures or as being a complication of acute otitis media. | We monitored children and queried parents regarding adverse events at each study visit, i.e. Day 4-5, Day 10-12, and Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this visit was 22.8. |
| The Distribution of Children With Nasopharyngeal (NP) Colonization With AOM Pathogens at the End-of-therapy Visit According to Treatment Assignment | AOM pathogens are defined as Streptococcus Pneumoniae or Haemophilus Influenzae or Moraxella Catarrhalis or Streptococcus Pyogenes. Nasopharyngeal cultures were obtained at the end of therapy visit. | End-of-therapy visit. The mean day for this visit was 11.6. |
| The Distribution of Children With Nasopharyngeal (NP) Colonization With Penicillin-susceptible Streptococcus Pneumoniae (S. pn) at the End-of-therapy Visit According to Treatment Assignment | End-of-therapy visit. The mean day for this visit was 11.6. |
| The Distribution of Children With Nasopharyngeal (NP) Colonization With AOM Pathogens at the Follow-up Visit According to Treatment Assignment | AOM pathogens are defined as Streptococcus Pneumoniae or Haemophilus Influenzae or Moraxella Catarrhalis or Streptococcus Pyogenes. Nasopharyngeal cultures were obtained at the follow-up visit. | Follow-up visit. The mean day for this visit was 22.8. |
| The Distribution of Children With Nasopharyngeal (NP) Colonization With Penicillin-susceptible Streptococcus Pneumoniae (S. pn) at the Follow-up Visit | Follow-up visit. The mean day for this visit was 22.8. |
| The Probability of Middle Ear Effusion, Based on an Algorithm That Estimates the Probability of Middle Ear Effusion From an Interpretable Tympanographic Configuration, at the On-therapy Visit According to Treatment Assignment | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | On-therapy visit. The mean day for this visit was 5.0. |
| The Probability of Middle Ear Effusion, Based on an Algorithm That Estimates the Probability of Middle Ear Effusion From an Interpretable Tympanographic Configuration, at the End-of-therapy Visit According to Treatment Assignment | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | End-of-therapy visit. The mean day for this visit was 11.6. |
| The Probability of Middle Ear Effusion, Based on an Algorithm That Estimates the Probability of Middle Ear Effusion From an Interpretable Tympanographic Configuration, at the Follow-up Visit According to Treatment Assignment | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | Follow-up visit. The mean day for this visit was 22.8. |
| The Mean Number of Visits to a Primary Care Provider (PCP) According to Treatment Assignment | At each visit parents were asked if they had taken their child to his/her primary care physician since the last contact. Medical records were also reviewed. | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
| The Mean Number of Emergency Room Visits According to Treatment Assignment | At each visit we asked parents if they had to take their child to the emergency department. We also reviewed medical records to assure even more accurate reporting. | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
| The Mean Number of Antibiotic Prescriptions, Exclusive of Study Medication, According to Treatment Assignment | This is the number of times, in the course of the study, a child required treatment with an antibiotic other than the blinded study medication. | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
| The Total Number of Visits, Summed Across All Participants, at Which a Family Member Reported Having Missed Work According to Treatment Assignment | At each visit, parent or parents were asked if their child's illness had caused either parent to miss a day or partial day of work. The total number of visits is summed across all participants in the respective treatment arms. | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
| The Total Number of Visits, Summed Across All Participants, at Which a Family Member Reported Making Special Daycare Arrangements According to Treatment Assignment | At each visit, parent or parents were asked if their child's illness had caused them to make alternative daycare arrangements. The total number of visits is summed across all participants in the respective treatment arms. | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
| The Mean Score Representing Parental Satisfaction With the Study Medication As Recorded at the On-therapy Visit According to Treatment Assignment | Parents were asked to circle the expression that best represented their satisfaction with the study medication. These expressions have an assigned value: Very dissatisfied = 1, Somewhat dissatisfied = 2, Neither satisfied nor dissatisfied = 3, Somewhat satisfied = 4 and Very satisfied = 5. | On-therapy visit. The mean day for this visit was 5.0. |
| The Mean Score Representing Parental Satisfaction With the Study Medication As Recorded at the End-of-therapy Visit According to Treatment Assignment | Parents were asked to circle the expression that best represented their satisfaction with the study medication. These expressions have an assigned value: Very dissatisfied = 1, Somewhat dissatisfied = 2, Neither satisfied nor dissatisfied = 3, Somewhat satisfied = 4 and Very satisfied = 5. | End-of-therapy visit. The mean day for this visit was 11.6. |
| The Mean Score Representing Parental Satisfaction With the Study Medication As Recorded at the Follow-up Visit According to Treatment Assignment | Parents were asked to circle the expression that best represented their satisfaction with the study medication. These expressions have an assigned value: Very dissatisfied = 1, Somewhat dissatisfied = 2, Neither satisfied nor dissatisfied = 3, Somewhat satisfied = 4 and Very satisfied = 5. | Follow-up visit. The mean day for this visit was 22.8. |
| 21098526 | Derived | Hoberman A, Paradise JL, Shaikh N, Greenberg DP, Kearney DH, Colborn DK, Rockette HE, Kurs-Lasky M, McEllistrem MC, Zoffel LM, Balentine TL, Barbadora KA, Wald ER. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila). 2011 Feb;50(2):114-20. doi: 10.1177/0009922810384259. Epub 2010 Nov 22. |
| BG002 | Total | Total of all reporting groups |
| participants |
|
| Gender | Count of Participants | Participants |
|
| Colonization With AOM Pathogens | AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes | Number | participants |
|
| Degree of tympanic membrane bulging | The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability. | Number | participants |
|
| Ethnicity | Parents were asked if their child is Hispanic. | Number | participants |
|
| Exposed to other children | Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week. Not exposed is defined as any child who does not meet this criteria. | Number | participants |
|
| Health insurance status | Parents were asked the child's health insurance status | Number | participants |
|
| History of recurrent acute otitis media | Records were obtained and reviewed for a history of recurrent acute otitis media. "Yes" indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year. "No" indicates that the child did not meet the criteria for "Yes". | Number | participants |
|
| Laterality of Acute Otitis Media | Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion. | Number | participants |
|
| Maternal Education | Parents were asked about the highest level of maternal education. | Number | participants |
|
| Race | Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race. | Number | participants |
|
| Severity of symptoms score | Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media. [tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14.](streamdown:incomplete-link) | Number | participants |
|
| Study Site | Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA. | Number | participants |
|
| Mean Estimated Probability of Middle Ear Effusion | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | Mean | Standard Deviation | probability of effusion |
|
| Mean score of AOM-SOS | This is the mean score for each arm. Parents completed the Acute Otitis Media -Severity of Symptoms (AOM-SOS) scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media. [tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14.](streamdown:incomplete-link) | Mean | Standard Deviation | AOM-SOS score |
|
| Placebo |
Reconstituted placebo in 2 divided doses for 10 days. |
|
|
|
| Secondary | The Distribution of Clinical Failures by the End-of-therapy Visit According to Treatment Assignment | Clinical failure by the end of therapy visit is defined as failure to achieve complete or virtually complete resolution of symptoms and of otoscopic signs, but without regard to the persistence of middle ear effusion. | The analysis was ITT. The number of participants equals the number of children evaluated post therapy plus the number of children who met the criteria for clinical failure prior to the end of therapy. | Posted | Number | participants | End-of-therapy visit. The mean day for this visit was 11.6. |
|
|
|
|
| Secondary | The Mean Acute Otitis Media - Severity of Symptom (AOM-SOS) Score, Post-enrollment, Over the First 7 Days of Therapy According to Treatment Assignment | The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) and recorded the ratings in a diary following enrollment on Day 1, twice daily Days 2 and 3, then once daily Days 4-7. Each set of ratings was summed to obtain an AOM-SOS score as a measure of symptom burden. The maximum possible score was 14 and the minimum was 0. | The analysis was ITT. The number of participants equals the number of children with at least one AOM-SOS score post-enrollment in the first 7 days of therapy. The score was based on AM and PM diaries completed at home by the child's parent. | Posted | Mean | Standard Deviation | AOM-SOS score | During the first 7 days of therapy |
|
|
|
|
| Secondary | The Distribution of Children Developing Worsening Symptoms Prior to Receiving 72 Hours of Study Medication According to Treatment Assignment | The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) and recorded the ratings in a diary following enrollment on Day 1 and twice daily Days 2 and 3. Each set of ratings was summed to obtain an Acute Otitis Media-Severity of Symptoms (AOM-SOS) score. We compared a child's AOM-SOS scores in the first 72 hours to his/her score at enrollment to determine if a child's symptoms got worse (score increased) or remained unchanged or improved (score remained same or decreased). | The analysis was ITT. The number of participants equals the number of children with follow-up whose parent(s) recorded AM and/or PM symptom scores in the first 3 days of treatment. | Posted | Number | Participants | Before receiving 72 hours of study medication |
|
|
|
|
| Secondary | The Mean Number of Times Analgesic Medication Was Administered to the Child According to Treatment Assignment | The parents were asked to complete a memory aid for the first 10 days of the study. One item asked them to record medications administered to the child in addition to the study medication. The data presented shows the mean number of times analgesic, i.e. ibuprofen or acetaminophen, was administered. | The analysis was ITT. The participants for analysis were the children with follow-up. | Posted | Mean | Standard Deviation | times analgesic was administered | The first 10 days of follow-up |
|
|
|
|
| Secondary | The Distribution of Children With Observed or Parent Reported Adverse Events or Complications According to Treatment Assignment | Analysis was limited to those adverse events identified as being associated with either the study medication or the antimicrobials administered to children who were treatment failures or as being a complication of acute otitis media. | The analysis was ITT. The number of participants equals the number of children randomized. | Posted | Number | participants | We monitored children and queried parents regarding adverse events at each study visit, i.e. Day 4-5, Day 10-12, and Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this visit was 22.8. |
|
|
|
|
| Secondary | The Distribution of Children With Nasopharyngeal (NP) Colonization With AOM Pathogens at the End-of-therapy Visit According to Treatment Assignment | AOM pathogens are defined as Streptococcus Pneumoniae or Haemophilus Influenzae or Moraxella Catarrhalis or Streptococcus Pyogenes. Nasopharyngeal cultures were obtained at the end of therapy visit. | The analysis was ITT. The number of participants equals the number of children with NP culture results at the end-of-therapy visit. | Posted | Number | participants | End-of-therapy visit. The mean day for this visit was 11.6. |
|
|
|
|
| Secondary | The Distribution of Children With Nasopharyngeal (NP) Colonization With Penicillin-susceptible Streptococcus Pneumoniae (S. pn) at the End-of-therapy Visit According to Treatment Assignment | The analysis was ITT. The number of participants equals the number of children with NP culture results and results regarding penicillin susceptibility at the end-of-therapy visit. | Posted | Number | participants | End-of-therapy visit. The mean day for this visit was 11.6. |
|
|
|
|
| Secondary | The Distribution of Children With Nasopharyngeal (NP) Colonization With AOM Pathogens at the Follow-up Visit According to Treatment Assignment | AOM pathogens are defined as Streptococcus Pneumoniae or Haemophilus Influenzae or Moraxella Catarrhalis or Streptococcus Pyogenes. Nasopharyngeal cultures were obtained at the follow-up visit. | The analysis was ITT. The number of participants equals the number of children with NP culture results at the follow-up visit. | Posted | Number | participant | Follow-up visit. The mean day for this visit was 22.8. |
|
|
|
|
| Secondary | The Distribution of Children With Nasopharyngeal (NP) Colonization With Penicillin-susceptible Streptococcus Pneumoniae (S. pn) at the Follow-up Visit | The analysis was ITT. The number of participants equals the number of children with NP culture results and results regarding penicillin susceptibility at the follow-up visit. | Posted | Number | participants | Follow-up visit. The mean day for this visit was 22.8. |
|
|
|
|
| Secondary | The Probability of Middle Ear Effusion, Based on an Algorithm That Estimates the Probability of Middle Ear Effusion From an Interpretable Tympanographic Configuration, at the On-therapy Visit According to Treatment Assignment | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | The analysis was ITT. The number of participants equals the number of children for which at least one ear has an interpretable tympanogram at the on-therapy visit. | Posted | Mean | Standard Deviation | probability of effusion | On-therapy visit. The mean day for this visit was 5.0. |
|
|
|
|
| Secondary | The Probability of Middle Ear Effusion, Based on an Algorithm That Estimates the Probability of Middle Ear Effusion From an Interpretable Tympanographic Configuration, at the End-of-therapy Visit According to Treatment Assignment | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | The analysis was ITT. The number of participants equals the number of children for which at least one ear has an interpretable tympanogram at the end-of-therapy visit. | Posted | Mean | Standard Deviation | probability of effusion | End-of-therapy visit. The mean day for this visit was 11.6. |
|
|
|
|
| Secondary | The Probability of Middle Ear Effusion, Based on an Algorithm That Estimates the Probability of Middle Ear Effusion From an Interpretable Tympanographic Configuration, at the Follow-up Visit According to Treatment Assignment | For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE. | The analysis was ITT. The number of participants equals the number of children for which at least one ear has an interpretable tympanogram at the follow-up visit. | Posted | Mean | Standard Deviation | probability of effusion | Follow-up visit. The mean day for this visit was 22.8. |
|
|
|
|
| Secondary | The Mean Number of Visits to a Primary Care Provider (PCP) According to Treatment Assignment | At each visit parents were asked if they had taken their child to his/her primary care physician since the last contact. Medical records were also reviewed. | The analysis was ITT. The participants for analysis were the children with follow-up assessment visits. | Posted | Mean | Standard Deviation | visits to PCP | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
|
|
|
|
| Secondary | The Mean Number of Emergency Room Visits According to Treatment Assignment | At each visit we asked parents if they had to take their child to the emergency department. We also reviewed medical records to assure even more accurate reporting. | The analysis was ITT. The participants for analysis were the children with follow-up assessment visits. | Posted | Mean | Standard Deviation | visits to ER | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
|
|
|
|
| Primary | The Time to Resolution of Symptoms, Defined as Acute Otitis Media-Severity of Symptoms (AOM-SOS) Score of 0 or 1, According to Treatment Assignment | Time to resolution of symptoms is defined as the time from randomization until a child's AOM-SOS score reaches 0 or 1. The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) and recorded the ratings in a diary following enrollment on Day 1, twice daily Days 2 and 3, then once daily Days 4-7. Each set of ratings was summed to obtain an AOM-SOS score. The maximum possible score was 14 and the minimum was 0. A score >=3 was required to be enrolled in the study. | The analysis was ITT. The number of participants is equal to the number of children randomized. | Posted | Number | participants | The first 7 days on therapy |
|
|
|
|
| Primary | The Time to Resolution of Symptoms, Defined as Acute Otitis Media-Severity of Symptoms (AOM-SOS) Score of 0 or 1 on Two Consecutive Occasions, According to Treatment Assignment | Time to resolution of symptoms is defined as the time from randomization until a child's AOM-SOS score reaches <= 1 on two consecutive occasions. The parent rated each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) as 0, 1 or 2 (none, a little, a lot) & recorded the ratings in a diary following enrollment on Day 1, twice daily Days 2 & 3, & once daily Days 4-7. Each set of ratings was summed to obtain an AOM-SOS score. The maximum possible was 14 and the minimum 0. A score >=3 was required to be enrolled in the study. | Posted | Number | participants | The first 7 days on therapy |
|
|
|
|
| Secondary | The Mean Number of Antibiotic Prescriptions, Exclusive of Study Medication, According to Treatment Assignment | This is the number of times, in the course of the study, a child required treatment with an antibiotic other than the blinded study medication. | The analysis was ITT. The participants for analysis were the children with follow-up. | Posted | Mean | Standard Deviation | antibiotic prescriptions | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
|
|
|
|
| Secondary | The Total Number of Visits, Summed Across All Participants, at Which a Family Member Reported Having Missed Work According to Treatment Assignment | At each visit, parent or parents were asked if their child's illness had caused either parent to miss a day or partial day of work. The total number of visits is summed across all participants in the respective treatment arms. | The analysis was ITT. The participants for analysis were the children with follow-up assessment visits. | Posted | Number | visits | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
|
|
|
|
| Secondary | The Total Number of Visits, Summed Across All Participants, at Which a Family Member Reported Making Special Daycare Arrangements According to Treatment Assignment | At each visit, parent or parents were asked if their child's illness had caused them to make alternative daycare arrangements. The total number of visits is summed across all participants in the respective treatment arms. | The analysis was ITT. The participants for analysis were the children with follow-up assessment visits. | Posted | Number | visits | This was assessed at each study visit, i.e. Day 4-5, Day 10-12, Day 21-25, and at interim visits. The last assessment was made at the Day 21-25 visit. The mean day for this latter visit was 22.8. |
|
|
|
|
| Secondary | The Mean Score Representing Parental Satisfaction With the Study Medication As Recorded at the On-therapy Visit According to Treatment Assignment | Parents were asked to circle the expression that best represented their satisfaction with the study medication. These expressions have an assigned value: Very dissatisfied = 1, Somewhat dissatisfied = 2, Neither satisfied nor dissatisfied = 3, Somewhat satisfied = 4 and Very satisfied = 5. | The analysis was ITT. The number of participants equals the number of children whose parent reported a satisfaction score at the on-therapy visit. | Posted | Mean | Standard Deviation | parental satisfaction score | On-therapy visit. The mean day for this visit was 5.0. |
|
|
|
|
| Secondary | The Mean Score Representing Parental Satisfaction With the Study Medication As Recorded at the End-of-therapy Visit According to Treatment Assignment | Parents were asked to circle the expression that best represented their satisfaction with the study medication. These expressions have an assigned value: Very dissatisfied = 1, Somewhat dissatisfied = 2, Neither satisfied nor dissatisfied = 3, Somewhat satisfied = 4 and Very satisfied = 5. | The analysis was ITT. The number of participants equals the number of children whose parent reported a satisfaction score at the end-of-therapy visit. | Posted | Mean | Standard Deviation | parental satisfaction score | End-of-therapy visit. The mean day for this visit was 11.6. |
|
|
|
|
| Secondary | The Mean Score Representing Parental Satisfaction With the Study Medication As Recorded at the Follow-up Visit According to Treatment Assignment | Parents were asked to circle the expression that best represented their satisfaction with the study medication. These expressions have an assigned value: Very dissatisfied = 1, Somewhat dissatisfied = 2, Neither satisfied nor dissatisfied = 3, Somewhat satisfied = 4 and Very satisfied = 5. | The analysis was ITT. The number of participants equals the number of children whose parent reported a satisfaction score at the follow-up visit. | Posted | Mean | Standard Deviation | parental satisfaction score | Follow-up visit. The mean day for this visit was 22.8. |
|
|
|
|
| Primary | The Weighted Average Acute Otitis Media - Severity of Symptom (AOM-SOS) Score, According to Treatment Assignment | The AOM-SOS score is derived from parent scoring each of 7 symptoms (ear tugging, crying, irritability, difficulty sleeping, diminished activity, diminished appetite & fever) associated with AOM as 0, 1 or 2 (none, a little, a lot). The AOM-SOS was administered twice daily the first 3 days of follow-up, then daily for 4 additional days. Symptom burden for each child is determined by calculating the weighted average of symptom scores post-enrollment over the first 7 days of therapy. Scores are weighted by 1/k, where k is the number of post-enrollment assessments taken on that day. | The analysis was ITT. The number of participants equals the number of children with at least one AOM-SOS score post-enrollment in the first 7 days of therapy. The score was based on diaries completed at home by the child's parent. | Posted | Mean | Standard Error | AOM-SOS score | During the first 7 days of therapy |
|
|
|
|
| 0 |
| 144 |
| 117 |
| 144 |
| EG001 | Placebo | Reconstituted placebo in 2 divided doses for 10 days. | 2 | 147 | 104 | 147 |
|
| Pneumonia | Respiratory, thoracic and mediastinal disorders | NIH Toxicity Tables | Systematic Assessment | One child developed pneumonia on study day three. The child was hospitalized and recovered uneventfully. After discharge the mother withdrew from the study. She felt it was too burdensome to complete the memory aid and come for follow-up visits. |
|
| Conjunctivitis | Eye disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Diaper dermatitis | Skin and subcutaneous tissue disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Fever | General disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Gastroenteritis | Gastrointestinal disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Oral thrush | Gastrointestinal disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Protocol defined diarrhea | Gastrointestinal disorders | NIH Toxicity Tables | Systematic Assessment | This is defined as 3 watery stools in 1 day or 2 watery stools for each of 2 consecutive days. |
|
| Teething | General disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Upper respiratory infection | Respiratory, thoracic and mediastinal disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Viral exanthem | Skin and subcutaneous tissue disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Viral illness | General disorders | NIH Toxicity Tables | Systematic Assessment |
|
| Vomiting | Gastrointestinal disorders | NIH Toxicity Tables | Systematic Assessment |
|
Not provided
Not provided
Not provided
| D000577 |
| Amides |
| D009930 | Organic Chemicals |
| D000658 | Amoxicillin |
| D000667 | Ampicillin |
| D010400 | Penicillin G |
| D010406 | Penicillins |
| D013457 | Sulfur Compounds |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D004338 | Drug Combinations |
| D004364 | Pharmaceutical Preparations |
| Day 2 PM |
|
| Day 3 AM |
|
| Day 3 PM |
|
| Day 4 |
|
| Day 5 |
|
| Day 6 |
|
| Day 7 |
|
| Protocol-defined diarrhea |
|
| Diaper dermatitis |
|
| Oral thrush |
|
| Vomiting |
|
| Rash |
|
Null hypothesis: There is no difference between the two treatment groups regarding the proportion of children with diaper dermatitis. |
| Regression, Logistic |
The comparison was adjusted for site, history of recurrent acute otitis media and exposure to other children. |
| <.01 |
| 95 |
| No |
| Superiority or Other |
| Null hypothesis: There is no difference between the two treatment groups regarding the proportion of children with oral thrush. | Regression, Logistic | The comparison was adjusted for site, history of recurrent acute otitis media and exposure to other children. | .07 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two treatment groups regarding the proportion of children with vomiting. | Regression, Logistic | The comparison was adjusted for site, history of recurrent acute otitis media and exposure to other children. | >.99 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two treatment groups regarding the proportion of children with rash. | Regression, Logistic | The comparison was adjusted for site, history of recurrent acute otitis media and exposure to other children. | >.99 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two treatment groups regarding the proportion of children with mastoiditis. | Regression, Logistic | The comparison was adjusted for site, history of recurrent acute otitis media and exposure to other children. | .99 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two treatment groups regarding the proportion of children with perforation of their tympanic membrane. | Regression, Logistic | The comparison was adjusted for site, history of recurrent acute otitis media and exposure to other children. | .08 | 95 | No | Superiority or Other |
| Presence of Streptococcus pneumoniae |
|
| Absence of Streptococcus pneumoniae |
|
| Presence of Haemophilus influenzae |
|
| Absence of Haemophilus influenzae |
|
| Presence of Moraxella catarrhalis |
|
| Absence of Moraxella catarrhalis |
|
| Presence of Streptococcus pyogenes |
|
| Absence of Streptococcus pyogenes |
|
Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Streptococcus pneumoniae present. |
| Regression, Logistic |
The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. |
| <.001 |
| 95 |
| No |
| Superiority or Other |
| Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Haemophilus influenzae present. | Regression, Logistic | The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. | .85 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Moraxella catarrhalis present. | Regression, Logistic | The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. | <.001 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Streptococcus pyogenes present. | Regression, Logistic | The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. | .28 | 95 | No | Superiority or Other |
| Presence of Streptococcus pneumoniae |
|
| Absence of Streptococcus pneumoniae |
|
| Presence of Haemophilus influenzae |
|
| Absence of Haemophilus influenzae |
|
| Presence of Moraxella catarrhalis |
|
| Absence of Moraxella catarrhalis |
|
| Presence of Streptococcus pyogenes |
|
| Absence of Streptococcus pyogenes |
|
Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Streptococcus pneumoniae present. |
| Regression, Logistic |
The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. |
| .03 |
| 95 |
| No |
| Superiority or Other |
| Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Haemophilus influenzae present. | Regression, Logistic | The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. | .96 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Moraxella catarrhalis present. | Regression, Logistic | The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. | .79 | 95 | No | Superiority or Other |
| Null hypothesis: There is no difference between the two groups regarding the proportion of culture results with Streptococcus pyogenes present. | Regression, Logistic | The comparison adjusted for site, history of recurrent acute otitis media and exposure to other children. | .98 | 95 | No | Superiority or Other |
| Resolved by Day 2 - AM |
|
| Censored by Day 2 - AM |
|
| Resolved by Day 2 - PM |
|
| Censored by Day 2 - PM |
|
| Resolved by Day 3 - AM |
|
| Censored by Day 3 - AM |
|
| Resolved by Day 3 - PM |
|
| Censored by Day 3 - PM |
|
| Resolved by Day 4 |
|
| Censored by Day 4 |
|
| Resolved by Day 5 |
|
| Censored by Day 5 |
|
| Resolved by Day 6 |
|
| Censored by Day 6 |
|
| Resolved by Day 7 |
|
| Censored by Day 7 |
|
| Resolved by Day 2 - AM |
|
| Censored by Day 2 - AM |
|
| Resolved by Day 2 - PM |
|
| Censored by Day 2 - PM |
|
| Resolved by Day 3 - AM |
|
| Censored by Day 3 - AM |
|
| Resolved by Day 3 - PM |
|
| Censored by Day 3 - PM |
|
| Resolved by Day 4 |
|
| Censored by Day 4 |
|
| Resolved by Day 5 |
|
| Censored by Day 5 |
|
| Resolved by Day 6 |
|
| Censored by Day 6 |
|
| Resolved by Day 7 |
|
| Censored by Day 7 |
|